An overview of pim kinase as a target in multiple myeloma.

Liu, Zhaoyun; Zhang, Yunhe; Guo, Yixuan; Wang, Hao; Fu, Rong

Liu, Zhaoyun; Zhang, Yunhe; Guo, Yixuan; Wang, Hao; Fu, Rong.

Afiliación

Liu Z; Department of Hematology, Tianjin Medical University General Hospital, Tianjin, People's Republic of China.
Zhang Y; Department of Hematology, Tianjin Medical University General Hospital, Tianjin, People's Republic of China.
Guo Y; Department of Hematology, Tianjin Medical University General Hospital, Tianjin, People's Republic of China.
Wang H; Department of Hematology, Tianjin Medical University General Hospital, Tianjin, People's Republic of China.
Fu R; Department of Hematology, Tianjin Medical University General Hospital, Tianjin, People's Republic of China.

Cancer Med ; 12(10): 11746-11759, 2023 05.

Article en En | MEDLINE | ID: mdl-37162273

Asunto(s)

Antineoplásicos; Enfermedades Óseas; Neoplasias Hematológicas; Mieloma Múltiple; Humanos; Mieloma Múltiple/patología; Antineoplásicos/farmacología; Antineoplásicos/uso terapéutico; Proteínas Proto-Oncogénicas c-pim-1; Inhibidores de Proteínas Quinasas/farmacología; Inhibidores de Proteínas Quinasas/uso terapéutico; Microambiente Tumoral

Palabras clave

bone disease; immune; multiple myeloma; pim kinase; tumor load

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedades Óseas / Neoplasias Hematológicas / Mieloma Múltiple / Antineoplásicos Límite: Humans Idioma: En Revista: Cancer Med Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google